NASDAQ:CTXR   Citius Pharmaceuticals, Inc.
test
Comment:
updating today
Comment:
The terminal corrective point for CTXR is this month. The max drawdown is about -30% from here if we fell more, which would be a blessing...since the upside is $5+ or about +462% from here. Accumulate accumulate accumulate
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.